This article announces Russia's launch of a free, personalized mRNA cancer vaccine, a significant advancement in oncology. The vaccine, utilizing cutting-edge mRNA technology similar to COVID-19 vaccines, is tailored to individual patients' genetic makeup, maximizing effectiveness while minimizing side effects. The article highlights the government's commitment to equitable healthcare access by providing the vaccine free to all citizens, contrasting with the high global cost of similar treatments. Finally, the piece places this Russian initiative within the broader context of global progress in cancer vaccine development, mentioning similar efforts in countries like the UK, US, Germany, and India.